ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_187 # 138760 # 138849 # 1 # ID=1_187;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.456	scaffold_1_187 	138760	138849	+	Strict	650	18.8606	vanC	100.0	3000368	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGGAATTGAATAAGGATAGAGTGGATGGGCCAATGGAGCTAATTGGTGTATGGTGGTGGTGGTACTGGTATGTGCTGGTTATGCACTGA	MELNKDRVDGPMELIGVWWWWYWYVLVMH	MKKIAVLFGGNSPEYSVSLTSAASVIQAIDPLKYEVMTIGIAPTMDWYWYQGNLANVRNDTWLEDHKNCHQLTFSSQGFILGEKRIVPDVLFPVLHGKYGEDGCIQGLLELMNLPYVGCHVAASALCMNKWLLHQLADTMGIASAPTLLLSRYENDPATIDRFIQDHGFPIFIKPNEAGSSKGITKVTDKTALQSALTTAFAYGSTVLIQKAIAGIEIGCGILGNEQLTIGACDAISLVDGFFDFEEKYQLISATITVPAPLPLALESQIKEQAQLLYRNLGLTGLARIDFFVTNQGAIYLNEINTMPGFTGHSRYPAMMAEVGLSYEILVEQLIALAEEDKR	8.45	gnl|BL_ORD_ID|423|hsp_num:0	455	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_941 # 714112 # 714249 # 1 # ID=1_941;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.457	scaffold_1_941 	714112	714249	+	Strict	500	23.483	aad(6)	100.0	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGCAGGTATACGAGTTTGTTGTTGTTATGTCATTTGCGTCAAGGTTGGAGGGAAGTGTGAAAAAAACCTATTTTGTCAGCGACATTGAGCCAATGGGTTGGGACATGTGGGCACCCCCACCGTTCCTGTTTTGCTAA	MQVYEFVVVMSFASRLEGSVKKTYFVSDIEPMGWDMWAPPPFLFC	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	16.30	gnl|BL_ORD_ID|1469|hsp_num:0	1562	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_1402 # 1072359 # 1072631 # 1 # ID=1_1402;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.421	scaffold_1_1402 	1072359	1072631	+	Strict	530	22.3274	OXA-899	100.0	3005093	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCGAGGCGAGGAGTCGAAAGAGGATAAGAGGATAAGAGGAGAAAGGGCAATTGAGTTTTTTCTGTGTGGGCTTTGCCTGCGCACGACTTACAAGCTGACTACGGGGAACAACATTGGACATGGCGGAGAAGATAAAAATAGCTTCAGTTGCATCACGGTAGGACAGGTAAAAAAGATGCAACAAGTACCTGGAGGCTGGTCTTTTGTCGCACAGGTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTCGATTTTCATCTCTTGGAGCTATGA	MRGEESKEDKRIRGERAIEFFLCGLCLRTTYKLTTGNNIGHGGEDKNSFSCITVGQVKKMQQVPGGWSFVAQVFFFFFFFFFFDFHLLEL	MMKRRHAATGALLAALATFAHAEHPICTIVADGATGKAVLQEGRCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGFMRRIVNRQLPVSARTYEMVDRTVQTWQVPGGWSVHGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALLARLPEVLAFAGQ	32.73	gnl|BL_ORD_ID|2869|hsp_num:0	3826	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_687 # 554521 # 554622 # -1 # ID=2_687;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.500	scaffold_2_687 	554521	554622	-	Strict	496	20.0162	IMP-68	100.0	3005019	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGATGGATGACGATGGATGGTTTGTTGAAAGGGGCGGAGAGAGGTGCCAAGAGATGTTTAGAGAGGAGCAGAGAAGGAAAAAGAGGCGTATCGTGGAATAG	MMDDDGWFVERGGERCQEMFREEQRRKKRRIVE	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPGHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	13.47	gnl|BL_ORD_ID|2810|hsp_num:0	3762	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_38 # 21999 # 22088 # -1 # ID=4_38;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.422	scaffold_4_38 	21999	22088	-	Strict	700	20.4014	adeS	100.0	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGGGTACATCGTTTCATTTCGTTGATAGTCGAGGGAAGGGAAAAAGGGAAGAAGAGAAGAAAGAAGAAGAGCGACATGGTTATTAA	MKGTSFHFVDSRGKGKREEEKKEEERHGY	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	8.03	gnl|BL_ORD_ID|169|hsp_num:0	183	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_326 # 246689 # 246817 # 1 # ID=4_326;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.465	scaffold_4_326 	246689	246817	+	Strict	600	20.0162	rgt1438	100.0	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGTATTCTGCAGTTTGCTTGGTGTCTGATGTGCTTGTATCGTTGCTGGTGGCTGGCTTAACGCCTGATGATCTTGTAGGTTCCCAGACGGCTGACATGGTATTAAGGTGCTTGGTTGATTTGAAGTGA	MYSAVCLVSDVLVSLLVAGLTPDDLVGSQTADMVLRCLVDLK	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	10.22	gnl|BL_ORD_ID|119|hsp_num:0	134	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_876 # 663285 # 663461 # 1 # ID=4_876;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.452	scaffold_4_876 	663285	663461	+	Strict	2000	21.9422	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	100.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGGGTGTGGAGAAAATATCAGGCACAGAAGGCGATTGGTTCGCGGTTCGTCGATTTGTCATGTGTCCAATAGAAAGTCCTTCCTCGGAACAACATTGTTGTCCCTTCGTTCCTGAGAGCACCTTCATAATTAACAAGTCGAACAGAATAGACCTGGAAAATGAAGGAATAGGGTAG	MGVEKISGTEGDWFAVRRFVMCPIESPSSEQHCCPFVPESTFIINKSNRIDLENEGIG	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	4.89	gnl|BL_ORD_ID|2668|hsp_num:0	2914	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_624 # 531429 # 531602 # 1 # ID=5_624;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.483	scaffold_5_624 	531429	531602	+	Strict	500	20.7866	OXA-192	100.0	3001766	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCCCATTGCGGGTCTTTTCTTCTGGGAATAGAATGCTTCAAACATACACACACACACACACACACACACACACACACACACTCCTCCTGTTCCCCTCTCTCGCCGAGGATGCGATCGATTGGTTATTTTTGTGGTTGGTTGGTTGGTTGGTTGGTTGGTTGGTGGGTTGA	MIPLRVFSSGNRMLQTYTHTHTHTHTHTLLLFPSLAEDAIDWLFLWLVGWLVGWLVG	MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	21.19	gnl|BL_ORD_ID|1196|hsp_num:1	1269	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_939 # 781209 # 781358 # 1 # ID=5_939;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.420	scaffold_5_939 	781209	781358	+	Strict	1300	20.4014	vanTN	100.0	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAGTGGGTTTGTGGTAGTCTGGCAGACAGTGGTGACAGTAGTGGGCAGTGGTGATGACAGTGGTCGCAATATTATCGATGATGATGATAATGGGTGGTGTTGGTGCGAAGGGAAGGTTGAATTTTTTTTTCAATTGATTTTTTTTTGA	MSGFVVVWQTVVTVVGSGDDSGRNIIDDDDNGWCWCEGKVEFFFQLIFF	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	7.00	gnl|BL_ORD_ID|1873|hsp_num:0	1983	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_448 # 355661 # 355843 # 1 # ID=6_448;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.525	scaffold_6_448 	355661	355843	+	Strict	1080	21.557	rosB	100.0	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAAGAAGAAAAAGGGTACCTGTTCCCAGCTGCTCGACCTTGGTGTAGTTGAGCTGGAGCAGCTCGTTGACCCAGGCGATAAGTTCTCCTCTGCTCTCAGACATGATGATGTTGGCGGTTGGTTGGTGGTGGGGGTTGGCGATGAAAAGAAACAACTTCTTGCACACTTCTGCCCCTGGTGA	MKKKKGTCSQLLDLGVVELEQLVDPGDKFSSALRHDDVGGWLVVGVGDEKKQLLAHFCPW	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	10.66	gnl|BL_ORD_ID|476|hsp_num:0	507	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_486 # 405341 # 405466 # 1 # ID=7_486;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.429	scaffold_7_486 	405341	405466	+	Strict	700	19.631	cmx	100.0	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTTGGTGAAGATGTTGTTGTTGTTGGTGGGAGTTGGGTATTTGCTGAACGTGAGAATGAAAAGAACAAAGGAAGGAAAGAAGGAAGAAGAGCGGCGTTGGCCGCCTTTTATGTTCTACAATTGA	MLVKMLLLLVGVGYLLNVRMKRTKEGKKEEERRWPPFMFYN	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	10.49	gnl|BL_ORD_ID|1283|hsp_num:0	1366	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_761 # 545184 # 545360 # 1 # ID=10_761;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.469	scaffold_10_761 	545184	545360	+	Strict	800	20.7866	Staphylococcus aureus LmrS	100.0	3004572	protein homolog model	n/a	n/a	macrolide antibiotic; aminoglycoside antibiotic; oxazolidinone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAACAAATCCGCAACCAAAAAAACACCGCCCTCTTTGGAACTACCTTCAGTCCCTCCCATTCCCGGGTCGGATCCAGATCGGATTAGTGATATGATCCCCTCTTTTGCTTTTGCGCGGGAATTGTTTGGATTGATGTTGTATGCATTCCCACCACTGTTACTCCCTCGTCATTAA	MNKSATKKTPPSLELPSVPPIPGSDPDRISDMIPSFAFARELFGLMLYAFPPLLLPRH	MAKVELTTRRRNFIVAVMLISAFVAILNQTLLNTALPSIMRELNINESTSQWLVTGFMLVNGVMIPLTAYLMDRIKTRPLYLAAMGTFLLGSIVAALAPNFGVLMLARVIQAMGAGVLMPLMQFTLFTLFSKEHRGFAMGLAGLVIQFAPAIGPTVTGLIIDQASWRVPFIIIVGIAILAFVFGLVSISSYNEVKYTKLDKRSVMYSTIGFGLMLYAFSSAGDLGFTSPIVIGALILSMVIIYLFIRRQFNITNALLNLRVFKNRTFALCTISSMIIMMSMVGPALLIPLYVQNSLSLSALLSGLVIMPGAIINGIMSVFTGKFYDKYGPRPLIYTGFTILTITTIMLCFLHTDTSYTYLIVVYAIRMFSVSLLMMPINTTGINSLRNEEISHGTAIMNFGRVMAGSLGTALMVTLMSFGAKIFLSTSPSHLTATEIKQQSIAIGVDISFAFVAVLVMAAYVIALFIREPKEIESNRRKF	12.08	gnl|BL_ORD_ID|2928|hsp_num:0	3276	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_737 # 497710 # 497841 # -1 # ID=12_737;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.447	scaffold_12_737 	497710	497841	-	Strict	400	20.7866	IMP-24	100.0	3002215	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGTTGCGTGCTTGTTTGTTTGTTCTTTGTGTGTGTGTGTGTGTGAGAGAGAGAGAGAGAGGAGAGAGAGTAAGAGCTGTACCTGACTCGATCGCCCTCATTCACATGGAGAAGGATTTTACGATTGGATGA	MLRACLFVLCVCVCVRERERGERVRAVPDSIALIHMEKDFTIG	MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESRKPSQPSN	17.48	gnl|BL_ORD_ID|1645|hsp_num:0	1746	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_856 # 570974 # 571078 # -1 # ID=12_856;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.467	scaffold_12_856 	570974	571078	-	Strict	500	21.9422	APH(3')-IIc	100.0	3002646	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGAAGAGGAGATGTGAGGAGGGGGGTAGGAGGTGGTACGAGTTGTTTGAAGGAAAAAGAGGAAAGATGGCAAACAACAAGGGTCTCGAGTGGAAAAGAGAATAA	MKRRCEEGGRRWYELFEGKRGKMANNKGLEWKRE	MEASNPFTDGLRLPRAWQEALADAHIERQSIGVSRADVARVHRPGQTDAFLKSEVIDAFSELGDEIARLRWLQAQGQSAPTVIATTEEGGRRWLLMSALPGRDLASSPELAPRRVAELLADALRGLHAVPVANCPFDQQLASRLQAAQARVEAGLVDADDFDDERLGQSPQQVFAELRATRPAHEDLVVSQGDACLPNLTVTDGRFTGFIDCGRLGVADRYQDLALAARSLVHNFGESRCVAALFQRYGAVPDERRLAFYRLLDEFF	12.73	gnl|BL_ORD_ID|961|hsp_num:0	1018	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_891 # 597204 # 597329 # 1 # ID=12_891;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.429	scaffold_12_891 	597204	597329	+	Strict	750	19.631	tet(E)	100.0	3000173	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTGATAAATATGCGGTTGGTTAGCCTTGATAGCCAAAATGGAGTAAGTAATGGTTGGGTATGGTGTCATTATCGAGCGCTTTTTTTTACCAAGGAGGAGGTCGTCGATGAGGATGAGGATTGA	MVINMRLVSLDSQNGVSNGWVWCHYRALFFTKEEVVDEDED	MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI	10.12	gnl|BL_ORD_ID|152|hsp_num:0	142	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_892 # 597870 # 598028 # 1 # ID=12_892;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.516	scaffold_12_892 	597870	598028	+	Strict	960	20.4014	efrA	100.0	3003948	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCCATTTTTGTGTACGTGTGTGTGTGGAATCAGATCAGGGAAGAGGAGGGAGTGACGCGAGCGGTTGGAGTAAGAGAGAATGAGAGGATTGAGAGTCGCTCCTTGTTGTTGTTCCTGAACGGCAGCGGTGCGGAAGAGTGTGAAAAGGACGGATGA	MAIFVYVCVWNQIREEEGVTRAVGVRENERIESRSLLLFLNGSGAEECEKDG	MKLMWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYVYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA	9.04	gnl|BL_ORD_ID|2239|hsp_num:0	2421	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_1213 # 845189 # 845701 # 1 # ID=12_1213;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.452	scaffold_12_1213 	845189	845701	+	Strict	500	23.483	sgm	100.0	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGCAAGGAAAGGATGAGGCTAGAAGAACAACGAAGGAAAGGTACATTGCTTACTCTCTTGTTCTCTTGTCGTTTAGGAGTAAACGTCCTTGGTCAAGTCTGAAAAGGAATGATAAAGGGATGAGGAAGAATAACGGCACAGATGTGAAAAAGGAATTTGTGGACTGCGGCTGCCTGCATAAAGAAAAACAATATTGTACAATTAGCAATTCAAGATGGAGGACAGGGGGGGAAATGGTTGAGCAGCAGGACATGACGGAACGGGCGGGCGACTTATCACACACAACAAAAAAAAAACAAAAAGGGTCGAAGTTATGCAATGCAACCCCCTTTGGTGTATATGTTGTAGTTTGTTTTCTCTGCTCTCCCCTTCATCCCTCATGTTCAATTTTCCCTTCGACTGCCCATTCTCTCTTTTTCCCTCAAGGAGAGGAGGGAAAGCACCACGCATTTGCAACCAAAGCGCGGTTTCCTGTTAGGTTCTTACCCCCCTCCCCCCCCAATGTATTCTAA	MQGKDEARRTTKERYIAYSLVLLSFRSKRPWSSLKRNDKGMRKNNGTDVKKEFVDCGCLHKEKQYCTISNSRWRTGGEMVEQQDMTERAGDLSHTTKKKQKGSKLCNATPFGVYVVVCFLCSPLHPSCSIFPSTAHSLFFPQGEEGKHHAFATKARFPVRFLPPSPPNVF	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	62.04	gnl|BL_ORD_ID|1952|hsp_num:0	2079	True	loose hit with at least 95 percent identity pushed strict
scaffold_16_713 # 562455 # 562550 # 1 # ID=16_713;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.427	scaffold_16_713 	562455	562550	+	Strict	800	20.4014	tet(48)	100.0	3004581	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTGTAATAGCAATAGTGAAGATGACAAGAGAATTAAGCAGGATGGAAAAATGGGAATAACGAGTTCGTCGAAAGAGGAGAGACGAGGGGGGTAG	MCNSNSEDDKRIKQDGKMGITSSSKEERRGG	MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK	7.77	gnl|BL_ORD_ID|2776|hsp_num:0	3284	True	loose hit with at least 95 percent identity pushed strict
scaffold_22_68 # 57389 # 57544 # -1 # ID=22_68;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.551	scaffold_22_68 	57389	57544	-	Strict	300	20.4014	dfrA23	100.0	3003019	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGGGGCGGACGAGCTGCCGTTGTTTTTGTTGGTGGTGTTATTAATGGCCTTGGGCGCATCTGGGACGGGACTTGAGCGAGTGGATCCCGTCGGTGGATTTGATTGGCTGCTGCTGTTTGTCTCCTTTTCGTCTTGCGGGCATGGTGTCGGCTAA	MGADELPLFLLVVLLMALGASGTGLERVDPVGGFDWLLLFVSFSSCGHGVG	MPTVEIIVAVDPVGGFGRNGQIPWTCKEDMKRFTTISKEIRVCVMGKNTYKDMLDMQMKKEGAEERIKEKGILPERESYVVSSTLKPEDVIGATVVPDLRAVLNQYHDSDQRIAVIGGEKLYVQALASATKVHMTVMHKPYNCDRTLPMSYIDKKFVAGQGSITIQTAVDGETHPVKFITYERARP	27.42	gnl|BL_ORD_ID|742|hsp_num:0	787	True	loose hit with at least 95 percent identity pushed strict
scaffold_22_435 # 346311 # 346403 # -1 # ID=22_435;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.366	scaffold_22_435 	346311	346403	-	Strict	496	19.631	IMP-68	100.0	3005019	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	ATGTTATTTGTTTTGTGTATTTTTCAAGGGGTGAACAAAAACGACAAAAACGAACGAGAGCCTTTGGGTGTGCTGCAGTACGAATTGAATTAA	MLFVLCIFQGVNKNDKNEREPLGVLQYELN	MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPGHSDIGDASLLKLTWEQAVKGLNESKKSNTVH	12.24	gnl|BL_ORD_ID|2810|hsp_num:0	3762	True	loose hit with at least 95 percent identity pushed strict
scaffold_29_599 # 446659 # 446889 # 1 # ID=29_599;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.485	scaffold_29_599 	446659	446889	+	Strict	750	21.557	tet(E)	100.0	3000173	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCATAGATGGTCTGATCGCATTGGAGTGAGTAAGCAGAAAAATAAAATGAGGGTTCATGTTTCTTACATTGTAGAGGCCGAGGAAGCCCTCGTTTCTGATTGTTTGGCGGAAGCAATCGAAGGGACCCTTGAAGATAGGGTGGTCCAAAGGCTGCGTCTGGAGACGGACCTTAACGGTGTCAAATGGGAACTCGACAAACTTGCCCGCCACACCCGCGATCTAATTTAG	MHRWSDRIGVSKQKNKMRVHVSYIVEAEEALVSDCLAEAIEGTLEDRVVQRLRLETDLNGVKWELDKLARHTRDLI	MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPLLGRWSDRIGRRPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHWFGMMGACFGGGMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINETTSSIREMISPLSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIAKHLGERKAIAVGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLTSLTHLTAVIGPLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI	18.77	gnl|BL_ORD_ID|152|hsp_num:0	142	True	loose hit with at least 95 percent identity pushed strict
scaffold_34_565 # 402947 # 403093 # 1 # ID=34_565;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.510	scaffold_34_565 	402947	403093	+	Strict	600	20.7866	AAC(3)-Ib/AAC(6')-Ib''	100.0	3002600	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3); AAC(6')	GTGTTCTTCGGGGGTGCGTTTGATAGGTGTGGGAGGGGTACAACCGGTTGGGTGAGGTTGAGCTGCCTCGATGGTGGTGGTGGTGACGGTTGGCTCGGTCATCTTGATGGGAATGTTTCTTTTTTTTCTTGTCGAAAAGAGAGATAA	MFFGGAFDRCGRGTTGWVRLSCLDGGGGDGWLGHLDGNVSFFSCRKER	MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	14.37	gnl|BL_ORD_ID|194|hsp_num:0	209	True	loose hit with at least 95 percent identity pushed strict
scaffold_35_124 # 85179 # 85328 # 1 # ID=35_124;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.507	scaffold_35_124 	85179	85328	+	Strict	2090	21.1718	mdsB	100.0	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGGGTTGTTGTTGGTAATGAGACAGCCCCCCCTCCTCCGGTCCCTGGCTGGTTTGCGGAGTTGAGTGACGGGCATTGGTTGGGGCGATTGAGTTTTATTAACGGTCTCCTCTTTTATGTCTTTCGATCATTGTATTTGACGATGTAG	MGVVVGNETAPPPPVPGWFAELSDGHWLGRLSFINGLLFYVFRSLYLTM	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	4.64	gnl|BL_ORD_ID|1301|hsp_num:0	1385	True	loose hit with at least 95 percent identity pushed strict
scaffold_39_392 # 335344 # 335451 # 1 # ID=39_392;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.398	scaffold_39_392 	335344	335451	+	Strict	760	19.631	Tet(X3)	100.0	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGAGTGAAAAAGGGACAGAGGGGAAGGATGAATGGAAGAATAAAGAACGAAAGGAATGGAGCGTAGATTTGCTATTTTACTCATGTGAAAAGTGCGTGGCTTTTTGA	MSEKGTEGKDEWKNKERKEWSVDLLFYSCEKCVAF	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	9.02	gnl|BL_ORD_ID|2308|hsp_num:0	3401	True	loose hit with at least 95 percent identity pushed strict
scaffold_39_459 # 384858 # 385091 # -1 # ID=39_459;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.432	scaffold_39_459 	384858	385091	-	Strict	700	21.557	tap	100.0	3000343	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAATGGGAAGGAGAAAGAAAGAAGGAAAAGAAGAGTTCGTTGCATCTGACGAGAATTCAGTTGAGCGCTCCCTCAAAGAAAGAGGTAAAGGTGAAAGAGAAGGAAAAGAAAGAAGGGGATAGGACGATGATCAATGGACGGTGGAGAGGTAATGAGGAGGAGTGCTACTATTTATCCGCTTCATTCTTTTCCGCCTTTTCTTTCAATGCTGGTGCCTTTTGTTGTTCATAG	MKWEGERKKEKKSSLHLTRIQLSAPSKKEVKVKEKEKKEGDRTMINGRWRGNEEECYYLSASFFSAFSFNAGAFCCS	MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATLIAGAAVDYLGRRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAGMTARETMLPEAAGRAGWTLDHANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGAFCCSILAISVLRLEGAGAPDRSVLTEAVLAGIVEGLRFVWYTPVLRTLAIVDLVATGLYMPMESVLFPKYFTDRNEPTELGWVLMALSIGGLLGALGYAVMSRYMSRRATMLTAVITLGVAMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTAPQHLRGRVVGVMGSLAYAAGPLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP	18.83	gnl|BL_ORD_ID|1621|hsp_num:0	1720	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_322 # 304970 # 305065 # -1 # ID=40_322;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.458	scaffold_40_322 	304970	305065	-	Strict	350	20.0162	Enterococcus faecalis chloramphenicol acetyltransferase	100.0	3004458	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCGCGGTTTTCTTTTGAGGTTTTGTGTTGAAGAAGCATTGGGATTGGAGGAGAATTGGGATAGAAAAGGGATGGCAATGGTGGGCGATGATTGA	MRGFLLRFCVEEALGLEENWDRKGMAMVGDD	MTFNIIELENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYEIYPSLIYAIMEVVNKNKVFRTGINSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDKNFISFYNNYKNDLLEYKDKEEMFPKKPIPENTIPISMIPWIDFSSFNLNIGNNSSFLLPIITIGKFYSENNKIYIPVALQLHHSVCDGYHASLFMNEFQDIIHRVDDWI	14.42	gnl|BL_ORD_ID|2570|hsp_num:0	2897	True	loose hit with at least 95 percent identity pushed strict
scaffold_53_159 # 100601 # 100993 # -1 # ID=53_159;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.478	scaffold_53_159 	100601	100993	-	Strict	450	23.0978	aadA17	100.0	3002617	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGGTCCCTAATGGAAAAGAAGATGGAGCAAGATGTCCTGAAGGAGTCTGGTTCGGAGGAGTACAACCCAGCTCTCCGAGAAACGCTCAAGCTGTGGATGAACGCGCTGTCAGGAAAGGTTATTCAGCGAGTATTCACGGAGAAGAGATTCTGCATGAACGATGAGGACATGGCGAGGTGTCTCAACAGCCCAAACGTAAATGCGATCTCATCTGTCGGAAACATCACGTTGGTGTCGGGGAAGATAAAGCATCCCATCGTAAAAGTCCCCTCCATCTGGAGTGTGTTCACGTACAGCTATGCCCGTAGTTATATGTACGAAAACGTTATCAAGAAGTCGACTACTAAGCTAGCTAGCCATGGATACAGACTGCTTGTTTTACCTACGTGA	MGSLMEKKMEQDVLKESGSEEYNPALRETLKLWMNALSGKVIQRVFTEKRFCMNDEDMARCLNSPNVNAISSVGNITLVSGKIKHPIVKVPSIWSVFTYSYARSYMYENVIKKSTTKLASHGYRLLVLPT	MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLTKAREHSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPKDVAADWAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK	49.43	gnl|BL_ORD_ID|472|hsp_num:0	502	True	loose hit with at least 95 percent identity pushed strict
scaffold_54_40 # 26262 # 26411 # 1 # ID=54_40;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.473	scaffold_54_40 	26262	26411	+	Strict	500	20.7866	bcr-1	100.0	3003801	protein homolog model	n/a	n/a	bicyclomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCAAGGGTATGTTGTTTTATGGGCCCTCGCTGCTCCCTATGTCGTCCTTTGACAGCTCGAGGGAGGTGTTACATGCGTTCACATATTACCAACTGCTGGAGACAGAATACCTTGGAGAGAGGAGAGAATTGATGACAAAATACTGA	MAKGMLFYGPSLLPMSSFDSSREVLHAFTYYQLLETEYLGERRELMTKY	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	12.19	gnl|BL_ORD_ID|2394|hsp_num:0	2303	True	loose hit with at least 95 percent identity pushed strict
scaffold_54_280 # 217947 # 218126 # -1 # ID=54_280;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.517	scaffold_54_280 	217947	218126	-	Strict	800	20.7866	PDC-461	100.0	3005294	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGCTCGTGTACGACGTCAACAACGCAAAGAGTTTCGAGACCTTGGAGAGCTGGAGAGACGAATTCTTGATTCAGGCCTCCCCTCGTGGACCCGAGAACTTCCCCTTTGTCGTCATTGGTAACAAGATCGATATGGAGGAGTCCAAGCGCATGGTAAGCCAGCACTGGCCTTTTTTTTGA	MLVYDVNNAKSFETLESWRDEFLIQASPRGPENFPFVVIGNKIDMEESKRMVSQHWPFF	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRVSQHWPALQGSRFDGISLLDLATYTAGGLPLKFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	14.86	gnl|BL_ORD_ID|3065|hsp_num:0	4026	True	loose hit with at least 95 percent identity pushed strict
scaffold_55_170 # 134961 # 135059 # -1 # ID=55_170;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.556	scaffold_55_170 	134961	135059	-	Strict	600	21.1718	vanHD	100.0	3002944	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGCCTTCGTCGTCGCTGGACTCGATATCGCTGGTGACGTTCTCGCGGGACTTGGGCGCCATGGTGTTTGGGTGTGAACGTGATGTGTTAGTGAGGTGA	MPSSSLDSISLVTFSRDLGAMVFGCERDVLVR	MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAELSEQLLLALKHAGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGTQKQNYCLNDCRGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVTLHVPLAEDTRHMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECTQKTIGHPYLSVLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV	9.91	gnl|BL_ORD_ID|1256|hsp_num:0	1333	True	loose hit with at least 95 percent identity pushed strict
scaffold_57_426 # 297908 # 298060 # -1 # ID=57_426;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.471	scaffold_57_426 	297908	298060	-	Strict	1000	21.557	ArnT	100.0	3005053	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCGAAGACGAATGAATTAGGTGAGTGTACTGGCGGAGGGAGCAAGGTATGTATTGCAATGAGGAGAAATAGAGCGAGGAAGCGATGGAGAGAGAAGAAAAGTAAGAAATCCAAGACAGAGATGCCCCATGGTATCATGCTCTGCGTTTGA	MAKTNELGECTGGGSKVCIAMRRNRARKRWREKKSKKSKTEMPHGIMLCV	MKSIRYGVSLIALFALYYLLPLNFRLLWQPDETRYAEISREMLATGDWVVPHFLGLRYFEKPIAGYWINSIGQWLFGHNNFGVRFGSVFAITMTALLVAWLAWRIFRDKRVAILSLIIFLTAMLVYAIGTYAVLDPMITLWLALAMCSFWGAVQAHSRSGKILGYVLLGVACGMGVMTKGFLALAVPVVGVLPWVIARKRWREVLTYGWLAVIVCTLVVLPWGLAIAQREPDFWRYFFWVEHIQRFAEKDAQHKAPFWYYIPFLIAGSLPWLALLPGALKRGWLERDEARGALYLLGWVAMPFLFFSIAKGKLPTYILPCFAPLSILMARYALEAAKTGAKALRINGMINLGVGLLGLIAVLVVSPWGFMHKPVWTKIELYKCLLAAIAFAVWALMGWLAMKDSGRRWSLAALCPLGLALLVGFAIPDRVIDSKQPQFLVDIVSESLQPSRYVLTNNVGIAGGLAWELKRSDIIMFDKQGELKYGLDWPDAQGSFVSQAGFADWLAAHRQQGPVSLVLLMDKGESMLDLPLPKPDNAYELGRVVFLQYLPQ	9.07	gnl|BL_ORD_ID|2841|hsp_num:0	3795	True	loose hit with at least 95 percent identity pushed strict
scaffold_59_187 # 147401 # 147508 # 1 # ID=59_187;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.528	scaffold_59_187 	147401	147508	+	Strict	700	19.631	cmx	100.0	3002703	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCGCAGTTTAGCTGACAGGAGGTGGCCACCAATTCCCATTATTGAAAATTTGTCCGGGGGTGGCCAAGAGGAAGAGGGTGGAGGATGTGAGAGCACTTTTCCCTAG	MRSLADRRWPPIPIIENLSGGGQEEEGGGCESTFP	MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAAFARRWPPRLTLIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANAGFLAVALSTATTLVPANQKGRALSILLSGTTIATVVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQLATPRLILAMALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGLVLAVGGPLLLTGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIGAAAGPVLGALGLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN	8.95	gnl|BL_ORD_ID|1283|hsp_num:0	1366	True	loose hit with at least 95 percent identity pushed strict
scaffold_59_322 # 252562 # 252711 # 1 # ID=59_322;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.407	scaffold_59_322 	252562	252711	+	Strict	500	22.3274	OXA-192	100.0	3001766	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTGGTCAAATGGTTGGTTGGTTGGTTGGCTTTGCATTACTTTGCCTGGGTCGTTAAAAGAAAAGGAACAAGCAAGGGAGTGGATGAATTCAAAAATACACACAACAATTACAACGCATAGTACAAAGAAGACACCATGGTGCTCATGA	MWSNGWLVGWLCITLPGSLKEKEQAREWMNSKIHTTITTHSTKKTPWCS	MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	18.22	gnl|BL_ORD_ID|1196|hsp_num:0	1269	True	loose hit with at least 95 percent identity pushed strict
scaffold_61_423 # 276244 # 276387 # 1 # ID=61_423;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.417	scaffold_61_423 	276244	276387	+	Strict	600	20.7866	Acinetobacter baumannii AbaQ	100.0	3004574	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGAGAAAAAGAAGTCTGGAAGAGACAGGGTATGCCGACGACAGGAGTGAGAGCGAAGGAGGAGAAAGAAAGAAAGGAAGGAAGACTATGAACATGGATGGAGGTGGTCAATGGTTAAAAAATGAATTGAATACTATTCAGTAA	MRKRSLEETGYADDRSESEGGERKKGRKTMNMDGGGQWLKNELNTIQ	MDFEKDVIRTVTFKLIPALVILYLVAYIDRAAVGFAHLHMGADVGIGDAAYGLGAGLFFIGYFLFEVPSNLLLDKFGARKWFTRILLTWGLITMAMALIQGPKSFYLLRFLLGVAEAGFFPGVLYLITQWYPVRHRGKIMGMFVLSQPIAMMIAGPLAGLLLGMDGIANLHGWQWLFVAVGLPAVLLALPTFLWLPDNIDKVKWLSIEQKQWLKNELVKDEAEYDQTRHANPLHALKDKRVLLLALYYLPVTLSIYGLNLWLPTIIKQFGGGSDIQIGFLSSIPYIFGIIGLLIIPRSTDRLNDRYGHLSFLYALGACAMFLSGWLNSPVMQLAALAVVAFCLFSSTAVFWTLPGRFLTGASAAAGIALINSVGNLGGYVGPFGIGLLKEYTGNMAAGLYFLSIVMLFGLILTYIVYAKLERQKTQTVNIQKPL	10.83	gnl|BL_ORD_ID|2773|hsp_num:0	3278	True	loose hit with at least 95 percent identity pushed strict
scaffold_65_33 # 34199 # 34339 # 1 # ID=65_33;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.433	scaffold_65_33 	34199	34339	+	Strict	200	20.7866	FosA	100.0	3000149	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	ATGGTTGAAAAGATGTTGGAGGGCCATATCCAACGAGGAATATATGATGATGGGGAGGGAAAAAAAAAAGAAGTGATAACAAACGGATCCTTGTGGCTGTGTCTGGGAAATGGTGAAAAGAAGGAAGGGTTGTCGGAGTGA	MVEKMLEGHIQRGIYDDGEGKKKEVITNGSLWLCLGNGEKKEGLSE	MLTGLNHLTLAVADLPASIAFYRDLLGFRLEARWDQGAYLELGSLWLCLSREPQYGGPAADYTHYAFGIAAADFARFAAQLRAHGVREWKQNRSEGDSFYFLDPDGHRLEAHVGDLRSRLAACRQAPYAGMRFAD	34.07	gnl|BL_ORD_ID|1223|hsp_num:0	1222	True	loose hit with at least 95 percent identity pushed strict
scaffold_67_29 # 19115 # 19303 # -1 # ID=67_29;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.476	scaffold_67_29 	19115	19303	-	Strict	1950	21.1718	MexB	100.0	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATAATGGAAGGAGGTTAAGAGAGAGAGAGGAGAAATCGCTCATCCACCTGACTGGTGAAGGACGAATGAAGAAAAGCGAACAACAGCAACAACGGCGACAAAAAGACGACAATGATGCTGCCGATGATGGAGGTGCTGTATCTGAACTGGGTGGATTTTTTGGCTGGGGGGCAACGAGTAAGTGA	MDNGRRLREREEKSLIHLTGEGRMKKSEQQQQRRQKDDNDAADDGGAVSELGGFFGWGATSK	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	5.93	gnl|BL_ORD_ID|1832|hsp_num:0	1925	True	loose hit with at least 95 percent identity pushed strict
scaffold_73_231 # 164161 # 164688 # 1 # ID=73_231;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.559	scaffold_73_231 	164161	164688	+	Strict	400	23.0978	Erm(K)	100.0	3004643	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGTTGGTGTGTGAGAGGGACATGAGGGTGTTTTTGTGGTCGTGTTCAGGACCGATAAGAGCCGATAGATCCTTTTCGGTATCGGTACCAGTCCTTTCCATCAGGCGCGTCGCGGGCGACGACGAGGACGACAAGGACGACCGGGGGTTAAATGCCGTAGGAGGAGTCTTCATCATCATGTCTGCAGCAGAGCCCGTCGACCCAGAGATGGGGATCGCCTGTGGAGGCATGTTGGAGATACCCCTGTGGCCAAGGCCAAGGCCAGTAGCTGTCTTGATGCTGGGTCGTGACAGCGGCATGTTGTTGTTAGAAGGCGAGGTAGACGACGACATGGAAGAGGGGATGACTGCAACGGAGTGTCGCTTCACGTCTCGAGACACCTTTGGAGAGAACACTCTAGGTGTAACAGTTGTGGACACCATGTCAGACATCATGACTCCACTGCCCGCAACAATAATCGCAGGGGAGGACAAAGTAGTCGCAGAAGAGGAGGATGCCGAGCGCGCCAGGGCCACGGGTAAGGAGTAA	MLVCERDMRVFLWSCSGPIRADRSFSVSVPVLSIRRVAGDDEDDKDDRGLNAVGGVFIIMSAAEPVDPEMGIACGGMLEIPLWPRPRPVAVLMLGRDSGMLLLEGEVDDDMEEGMTATECRFTSRDTFGENTLGVTVVDTMSDIMTPLPATIIAGEDKVVAEEEDAERARATGKE	MTKKKHKYSNKKLSRGEPPNFSGQHLMHNKKLLQEIVDQAKVSKKDTVLELGAGKGALTTFLSERAKRVLAVEYDQTFIQVLNRKMAHAANTTIIHEDIMRIHLPKGEFVVVSNIPYSITTPIMKKLLSNPVSGFQRGVIVMEKGAAKRFTSPFIKNAYVLAWRMWFDLEYVKGISRECFSPPPKVDSAMVFISRKPDPIVPYKDRSAFFGLAEYALREPKAPADSLLRGIFTATQLKHVKRNAGIKHDVSIGALSERQWGVIFETMTQYVRRPLWPRPRKTTL	61.62	gnl|BL_ORD_ID|2178|hsp_num:0	3341	True	loose hit with at least 95 percent identity pushed strict
scaffold_78_122 # 102923 # 103051 # 1 # ID=78_122;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.488	scaffold_78_122 	102923	103051	+	Strict	750	19.631	tet(Y)	100.0	3000182	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGAAAGGAAGAGAAGGGGGGTAAACGTGGATGGGATGGGTGGGTGGCAAAGGGACTCAATCATACTCCGGTGCACAAACCCAACAAAAACAAAATAATAATCAACAAAGCTGCGGAGAGGGGCTGA	MGKEEKGGKRGWDGWVAKGLNHTPVHKPNKNKIIINKAAERG	MSKSLITALIVVALDAIGLGLIMPVVPALLNEFVPAEQTAFHYGVFLSLYAFMQVFCAPVLGRLSDRYGRRIILLVSFLGATIDYSIMAAAPVLWVLYIGRIISGVTGATGAIAASIIADTTKQEERARWFGFMGACFGAGMIAGPAIGGVLGDISVHAPFVAGALLNAIAFCLVAFLLPKTPSQPPEGQPAKINLFEGFRFNFAVQGLASFFALFFLMQLIGQAPAALWVIYGEQRLNWDIGTAGVSLAVFGAAHTFVQAVLTGTLSKRLGDRGVLLLGMGADMCGFLLLAFITQSWMVLPAIFMLATGGIGMPALQAIISGLVCDEKQGALQGTLTGLTNITSIIGPVGFTTLYGLTAGQWDGWVWLVAASLYLIAIPLLRQSASLLRS	10.74	gnl|BL_ORD_ID|453|hsp_num:0	402	True	loose hit with at least 95 percent identity pushed strict
scaffold_81_42 # 37366 # 37512 # 1 # ID=81_42;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.503	scaffold_81_42 	37366	37512	+	Strict	2000	20.0162	oqxB	100.0	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGGGTAATTACGAGGACAGCGAAGGAGAAAGAGAAGGGGGGAGTGAAGATGCCTGAGATGATGTGTCCGTTGAAGAGGATGAACTGTCCGAGAGAAAGAGAGAAAGAGAGACGGAGTGAGGAGGGAGAGGAAAAGGGGAAGTAG	MRVITRTAKEKEKGGVKMPEMMCPLKRMNCPREREKERRSEEGEEKGK	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	4.57	gnl|BL_ORD_ID|2211|hsp_num:0	2400	True	loose hit with at least 95 percent identity pushed strict
scaffold_107_54 # 45597 # 45761 # 1 # ID=107_54;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.436	scaffold_107_54 	45597	45761	+	Strict	600	21.9422	vanHF	100.0	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGATTGACAAGAGGACGCTGGAAAAATATGAGAAGGATGCTAAAGAGGCTGGACGGGACTCTTGGTATCTATCCTGGGCGCTGGATACTAACGCAGAGGAGCGTGCCAAGGTAACTTTGCATTTATTTTACTTTGACTGCACACTATTGACAGAAAATCATTGA	MIDKRTLEKYEKDAKEAGRDSWYLSWALDTNAEERAKVTLHLFYFDCTLLTENH	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	16.77	gnl|BL_ORD_ID|1691|hsp_num:0	1790	True	loose hit with at least 95 percent identity pushed strict
scaffold_124_56 # 69581 # 69691 # -1 # ID=124_56;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.532	scaffold_124_56 	69581	69691	-	Strict	500	21.557	OXA-379	100.0	3001565	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGCAATTCGTTGGGCGAGTTCAGGGATGGCGAGGATCTTGTTGGGGGTATGCTGGCTTTTGCTGTAGTTGATGGTTGGGAGTGGGATGTCATTTCAGGCGGTGATTAG	MGNSLGEFRDGEDLVGGMLAFAVVDGWEWDVISGGD	MNIKALLLITSAIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWEWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	13.14	gnl|BL_ORD_ID|1792|hsp_num:0	1898	True	loose hit with at least 95 percent identity pushed strict
scaffold_136_55 # 50250 # 50465 # 1 # ID=136_55;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.421	scaffold_136_55 	50250	50465	+	Strict	1000	23.483	MCR-1.10	100.0	3004506	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGATGGGTGCGAATTTCGATTATCCGACATGGGGGAAGGAAAGAGTTTGGGGGTATCTACACTCTTTTTTTCGATTTGCCGCATTTTCACTATGGCAAATGCGGTATTTCACTGAATTAAAATATATGCTCGTGGCTATTCAATCGATTTTTAATTTTGCATGGAATTACGGACAACAAATCGTGCGACTGCTCGAGCCTTTGGGTCGTCGCTAG	MMGANFDYPTWGKERVWGYLHSFFRFAAFSLWQMRYFTELKYMLVAIQSIFNFAWNYGQQIVRLLEPLGRR	MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDTRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNTICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	13.12	gnl|BL_ORD_ID|2731|hsp_num:0	3134	True	loose hit with at least 95 percent identity pushed strict
scaffold_172_20 # 9585 # 9728 # -1 # ID=172_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.465	scaffold_172_20 	9585	9728	-	Strict	500	21.1718	OXA-12	100.0	3001407	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGTAATGCTCATTCCTTGGCGAAGAACCATATCGATGATCGTCTGACGAGTGTGATCGTCGATTTTGTTATATCTCCTTCGTATGATGGGTGGCATGGTAGTGCAAGGAGTGCTGTAGATGGTGAGTGTGAGTGTGAGTGA	MGNAHSLAKNHIDDRLTSVIVDFVISPSYDGWHGSARSAVDGECECE	MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL	17.80	gnl|BL_ORD_ID|172|hsp_num:0	186	True	loose hit with at least 95 percent identity pushed strict
